Chinese University of Hong Kong, Hong Kong,China
Professor Anthony Chan graduated from the School of Medicine in University College London and received post-graduate training in Medical Oncology at the Royal Marsden Hospital, UK, and joined The Chinese University of Hong Kong in 1993 where he is currently Li Shu Fan Medical Foundation Professor of Clinical Oncology, Director of the Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, Chief Director of Phase 1 Clinical Trial Centre, Associate Director of State Key Laboratory of Translational Oncology, Associate Dean (Institutional Affairs) of Faculty of Medicine and Master of Wu Yee Sun College. Professor Chan conducted pivotal studies setting new treatment standards in multimodality approaches in nasopharynx cancer, developed the clinical applications of the biomarker EBV DNA and pioneered immunotherapeutic and targeted therapeutics in this disease. He has published over 400 peer-reviewed papers, 53 book chapters and reviews, and delivered over 170 international lectures. He has served on the Editorial Board of Journal of Clinical Oncology and is currently Associate Editor of Annals of Oncology.